[Finnegan, Henderson, Farabow, Garrett & Dunner, LLP / FRONTEO co-sponsored online seminar]

Managing partner of the Atlanta office, John Livingstone is a primary attorney specializing in complex pharmaceutical, chemical and biotechnology patent litigation before the United States District Court, the United States International Trade Commission (ITC) and the United States Court of Appeals for the Federal Circuit. He is a line trial attorney and has also served as lead counsel in post-grant patent litigation before the United States Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB).He has also served as lead counsel in post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO).He also spent four years in Finnegan's Tokyo office and frequently serves global clients on US patent matters.

We also advise clients on a variety of patent matters, including strategic portfolio management and due diligence assessments related to M&A and in-licensing.

He is a regular speaker on patent law and has authored numerous legal and scientific papers.In addition, he regularly speaks to national and international audiences such as the Institute for International Intellectual Property Protection (AIPPI) in Singapore and Seoul, LexisNexis in Shenzhen, and Japan Licensing Society (JLES) in Tokyo.Japan Patent Attorneys Association (Tokyo, Osaka, Shikoku), American Intellectual Property Law Association (AIPLA) Chemical Prosecution Bootcamp (Minneapolis, Houston), Chemical Practice Group meeting (Houston), Roundtable at Managing Intellectual Property (Tokyo), etc. I give lectures internationally.

Since 2013, he has been named IP Star of Georgia by Managing Intellectual Property. Since 2016, he has been ranked among the top US patent attorneys in the Legal Media Groups Guide to the World's Leading Patent Law Practitioners. Intellectual Property recognized by LMG Life Sciences as General Patent Litigator of the Year South. A Life Sciences Star and for his contributions to the Hatch-Waxman Patent Litigation. LMG Life, Kaken Pharmaceutical Co., Ltd.; LMG Life, both of whom led the firm's appeals court victory in Bausch Health Care v. Andrei Iancu and district court victory in AstraZeneca AB v. Aurobindo Ltd et al. Selected as Impact Cases of the Year at the Sciences Awards.

David Weingarten focuses on patent litigation before the U.S. District Court and the U.S. International Trade Commission (ITC), post-grant proceedings before the U.S. Patent and Trademark Office (USPTO), patent practice, and strategic portfolio management. Widely used in the life science field.He also has extensive experience in preparing and practicing US patent applications, coordinating and managing foreign practices, developing strategies for portfolio management and planning, and participating in diligence projects for domestic and international clients. doing.In addition, he drafts patent infringement, validity and enforceability opinions, and prepares intellectual property agreements, including licensing and supply agreements.

He currently serves on the Food and Drugs Committee of the American Intellectual Property Law Association (AIPLA), the national bar association of intellectual property professionals. She was featured on Best Lawyers' "Ones to Watch" list in 2020 and 2021, and in 2021 she was named a Fellow of the American Bar Foundation.In 2022, Intellectual Asset Management magazine recognized him as a persuasive attorney in major pharmaceutical and biotechnology litigation.He has spoken at numerous industry and bar association meetings across the country, including the American Chemical Society (ACS), American Bar Association (ABA), and New Jersey Intellectual Property Law Association (NJIPLA), and has spoken at various conferences in Strafford. He is a frequent lecturer on the subject of patent law.

Prior to practicing law, he spent more than 10 years in the pharmaceutical industry involved in drug development across a wide range of therapeutic areas, including cardiovascular, metabolic, respiratory and inflammation.As senior management, he was responsible for leading research and development in drug discovery, process research and development, and manufacturing.He was also responsible for preparing new drug applications, due diligence and managing technology transfer.

While at Emory Law School, he was a Robert W. Woodruff Fellow, Chancellor's Education Fellow, received awards for academic excellence in contract writing, negotiation, transaction skills, patents and global health, and trade negotiations at Emory Law School. won 1st place.He was also an Achievement Rewards for College Scientists (ARCS) Scholar, a Northern Telecom Scholar, a Department of Education graduate student, and an American Chemical Society Organics Division graduate student at Emory University.

Attorney Paul Townsend's patent practice spans litigation, practice, and client counseling.He primarily supports companies in polymer composition and manufacturing, specialty chemicals, catalysts, coating technology, pharmaceuticals and energy technology.

We represent clients in federal district court litigation, Section 337 investigations before the International Trade Commission (ITC), and inter partes reviews (IPRs) before the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO).Experienced in all stages of litigation, including drafting answers, interpreting claims, dealing with all aspects of discovery, working with expert witnesses to formulate infringement, validity, and invalidity positions, expert This includes working with witnesses to prepare expert reports and declarations, drafting and responding to motions, legal investigations, day-to-day litigation activities, court preparation and attendance.

Attorney Paul has extensive experience in prosecution and client counseling.She supports both the formulation and drafting of intellectual property policies, the drafting and practice of patent applications, the coordination of foreign practices, and related licensing and pre-litigation due diligence analyses.She has also drafted opinions on invalidity, validity, infringement, non-infringement and freedom of business in a variety of chemical-related technology areas.

In particular, I am interested in energy-related technologies.Prior to law school, I interned in the upstream and downstream operations of an oil and gas company and a nuclear power company.At Queen's University, he earned a degree in Chemical Engineering and worked on several projects related to renewable and alternative energy, including biofuels and solar technology.Because of his interest in energy and other climate technologies, he is a frequent speaker at the Chemical Engineering and Law Forums at the American Society of Chemical Engineers Annual and Spring Meetings.

I regularly participate in various pro bono programs at Finnegan.At the DC Bar Pro Bono Center, he also represented a veteran with multiple disabilities in a veteran's claims court appeals denial of veteran benefits, and a tenant in a landlord-tenant dispute.He also assisted in preparing the Amicus Brief filed with the Connecticut Supreme Court in relation to expert testimony on forensic and scientific evidence in criminal cases.Selected for the "Capital Pro Bono Honor Role" for several years in a row.